(19)
(11) EP 0 663 839 A1

(12)

(43) Date of publication:
26.07.1995 Bulletin 1995/30

(21) Application number: 93921709.0

(22) Date of filing: 21.09.1993
(51) International Patent Classification (IPC): 
A61K 31/ 19( . )
A61K 31/ 415( . )
A61K 31/ 445( . )
A61P 29/ 00( . )
A61K 31/ 34( . )
A61K 31/ 425( . )
A61P 25/ 04( . )
(86) International application number:
PCT/US1993/008947
(87) International publication number:
WO 1994/007541 (14.04.1994 Gazette 1994/09)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30) Priority: 29.09.1992 US 19920953440

(71) Applicants:
  • MERCK & CO. INC.
    Rahway New Jersey 07065-0900 (US)
  • McNEIL-PPC, INC.
    Milltown New Jersey 08850 (US)

(72) Inventors:
  • SIMS, Robert, T.
    Holicong, PA 18928 (US)
  • SLIVKA, William
    Philadelphia, PA 19118 (US)
  • GATES, Thomas, N.
    Doylestown, PA 18901 (US)
  • MCMAHON, Robert
    Flemington, NJ 08822 (US)

(74) Representative: Cole, William Gwyn, et al 
European Patent Department Merck & Co., Inc. Terlings Park Eastwick Road
Harlow Essex CM20 2QR
Harlow Essex CM20 2QR (GB)

   


(54) IBUPROFEN-H 2? ANTAGONIST COMBINATIONS